These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23863918)

  • 21. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of activated charcoal on citalopram-induced QT prolongation.
    Greene SC; Brooks DE; Lovecchio F
    Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin syndrome associated with the use of escitalopram.
    Huska MT; Catalano G; Catalano MC
    CNS Spectr; 2007 Apr; 12(4):270-4. PubMed ID: 17426664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the risk of QT prolongation among SSRIs.
    Funk KA; Bostwick JR
    Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SSRI enantiomers already effective after 8 days. The proper twist against depression].
    MMW Fortschr Med; 2003 Nov; 145(47):60. PubMed ID: 14725038
    [No Abstract]   [Full Text] [Related]  

  • 26. Considerations on safety concerns about citalopram prescribing.
    Sheeler RD; Ackerman MJ; Richelson E; Nelson TK; Staab JP; Tangalos EG; Dieser LM; Cunningham JL
    Mayo Clin Proc; 2012 Nov; 87(11):1042-5. PubMed ID: 23018033
    [No Abstract]   [Full Text] [Related]  

  • 27. An electrocardiograph should be examined in patients with a hypersensitive esophagus before a trial of citalopram.
    Lee TH; Lee JS
    Am J Gastroenterol; 2013 May; 108(5):854. PubMed ID: 23644968
    [No Abstract]   [Full Text] [Related]  

  • 28. Escitalopram-Associated Tongue Hypoesthesia.
    Chauhan A; Praharaj SK
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):346-347. PubMed ID: 33657072
    [No Abstract]   [Full Text] [Related]  

  • 29. A critical evaluation of the cardiac toxicity of citalopram: part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classroom Enters the Courtroom: Stereochemistry of SN1 and SN2 Reactions in Enantiomer Patent Litigations of the Antidepressant Escitalopram.
    Michman E; Agranat I
    Chirality; 2016 Jan; 28(1):39-43. PubMed ID: 26477341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-Dependent Escitalopram-Associated Ventricular Bigeminy.
    Naguy A; Al-Humoud AM; AlAwadhi DS; Khraibut B
    Am J Ther; 2020; 27(3):e307-e309. PubMed ID: 31567151
    [No Abstract]   [Full Text] [Related]  

  • 34. Unintended Consequences of Adjusting Citalopram Prescriptions Following the 2011 FDA Warning.
    Gerlach LB; Kales HC; Maust DT; Chiang C; Stano C; Choe HM; Zivin K
    Am J Geriatr Psychiatry; 2017 Apr; 25(4):407-414. PubMed ID: 28012712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin syndrome in the elderly after antidepressive monotherapy.
    Fischer P
    J Clin Psychopharmacol; 1995 Dec; 15(6):440-2. PubMed ID: 8748434
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SSRIs and ejaculation.
    Robbins A
    J Clin Psychopharmacol; 2003 Feb; 23(1):108; author reply 108-9. PubMed ID: 12544388
    [No Abstract]   [Full Text] [Related]  

  • 38. Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.
    Leonard B; Taylor D
    J Psychopharmacol; 2010 Aug; 24(8):1143-52. PubMed ID: 20147575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT; Lee Y; Lin YE; Lin PY
    Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.
    Zhang L; Rasenick MM
    J Pharmacol Exp Ther; 2010 Mar; 332(3):977-84. PubMed ID: 19996298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.